Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 3/20 | 0.86 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.86 |
| ▸ | MEN1 | O00255 | 2/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.79 |
| ▸ | GLA | P06280 | 1/20 | 0.79 |
| ▸ | TSHR | P16473 | 3/20 | 0.73 |
| ▸ | KDM1A | O60341 | 5/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | SAT1 | P21673 | 3/20 | 0.52 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | F13A1 | P00488 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CA6 | P23280 | 2/20 | 0.39 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | THPO | P40225 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL332342 | 0.96 | CYP2C19 (0.80) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| Diethylhomospermine SCHEMBL426504 | 0.96 | CYP2C19 (0.93) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| SCHEMBL19620508 | 0.96 | CYP2C19 (0.80) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| SCHEMBL331540 | 0.96 | CYP2C19 (0.80) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| SCHEMBL7089751 | 0.96 | CYP2C19 (0.80) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| SCHEMBL429223 | 0.96 | CYP2C19 (0.93) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| SCHEMBL331498 | 0.96 | CYP2C19 (0.80) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| SCHEMBL13893419 | 0.96 | CYP2C19 (0.80) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| Hydrochloric Acid SCHEMBL3877574 | 0.93 | CYP2C19 (0.87) | CYP2C19CYP1A2MEN1KMT2AGLA | |
| SCHEMBL6899291 | 0.93 | CYP2C19 (1.00) | CYP2C19CYP1A2MEN1KMT2AGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 597 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113831258-A | Method for synthesizing terephthalic acid dihydrazine | 东莞理工学院 | 2021-12-24 | — | — | CN | claimed |
| US-10067266-B2 | Method of producing resin for thiourethane-based optical material using general-purpose polyisocyanate compound, resin composition for thiourethane-based optical material and thiourethane-based optical material including resin produced by the method | KOC SOLUTION CO., LTD. (KR) | 2018-09-04 | — | — | US | claimed |
| EP-2682430-B1 | METHOD FOR MANUFACTURING RESIN FOR THIOURETHANE-BASED OPTICAL MATERIAL USING UNIVERSAL POLYISOCYANATE COMPOUND, RESIN COMPOSITION, AND OPTICAL MATERIAL MANUFACTURED THEREBY | KOC SOLUTION CO LTD (KR) | 2015-10-21 | — | — | EP | claimed |
| US-20140039145-A1 | METHOD OF PRODUCING RESIN FOR THIOURETHANE-BASED OPTICAL MATERIAL USING GENERAL-PURPOSE POLYISOCYANATE COMPOUND, RESIN COMPOSITION FOR THIOURETHANE-BASED OPTICAL MATERIAL AND THIOURETHANE-BASED OPTICAL MATERIAL INCLUDING RESIN PRODUCED BY THE METHOD | KOC SOLUTION CO LTD (KR) | 2014-02-06 | — | — | US | claimed |
| EP-2682430-A2 | METHOD FOR MANUFACTURING RESIN FOR THIOURETHANE-BASED OPTICAL MATERIAL USING UNIVERSAL POLYISOCYANATE COMPOUND, RESIN COMPOSITION, AND OPTICAL MATERIAL MANUFACTURED THEREBY | Koc Solution Co.,LTD. (KR) | 2014-01-08 | — | — | EP | claimed |
| EP-1637557-B1 | Polyacetal resin composition | MITSUBISHI GAS CHEMICAL CO (JP) | 2012-01-11 | — | — | EP | claimed |
| US-20060063863-A1 | Polyacetal resin composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2006-03-23 | — | — | US | claimed |
| EP-1637557-A1 | Polyacetal resin composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2006-03-22 | — | — | EP | claimed |
| US-3951914-A | Process for preparing poly(1,4-benzamide) in cyclic sulfone media | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-04-20 | — | — | US | claimed |
| JP-56104940-A | — | — | None | — | — | JP | disclosed |
| EP-4332140-B1 | POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, POLYMERIZABLE PREPOLYMER COMPOSITION FOR OPTICAL MATERIAL, CURED PRODUCT, AND METHOD OF PRODUCING OPTICAL MATERIAL | MITSUI CHEMICALS INC (JP) | 2026-05-27 | — | — | EP | disclosed |
| EP-4741436-A1 | POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, POLYMERIZABLE PREPOLYMER COMPOSITION FOR OPTICAL MATERIAL, CURED ARTICLE, AND METHOD FOR PRODUCING OPTICAL MATERIAL | Mitsui Chemicals, Inc. (JP) | 2026-05-13 | — | — | EP | disclosed |
| US-12624265-B2 | Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof | ADEKA CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| US-12620777-B2 | Optical member, laser module including said optical member, and laser device | DAICEL CORPORATION (JP) | 2026-05-05 | — | — | US | disclosed |
| EP-0006150-A1 | Process for preparing light-stable polyurethane integrated foams | BASF Aktiengesellschaft (DE) | 1980-01-09 | — | — | EP | disclosed |
| US-4179469-A | Preparation of amines | UOP INC. (US) | 1979-12-18 | — | — | US | disclosed |
| US-4098846-A | IMPACT STRENGTH | GENERAL ELECTRIC COMPANY (US) | 1978-07-04 | — | — | US | disclosed |
| US-4054553-A | MANGANESE COMPLEX CATALYST | GENERAL ELECTRIC COMPANY (US) | 1977-10-18 | — | — | US | disclosed |
| US-3991016-A | Poly(1,4-benzamide) copolymers | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-11-09 | — | — | US | disclosed |
| US-3951914-A | Process for preparing poly(1,4-benzamide) in cyclic sulfone media | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624265-B2 | Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof | SORD, SUCLA2, SUCLG1 | CYP2C19 4010/4885CYP1A2 2298/4885MEN1 2208/4885 |
| US-12620777-B2 | Optical member, laser module including said optical member, and laser device | MARK3, OR10J3, ILK | CYP2C19 3838/4885CYP1A2 4264/4885MEN1 3920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.